• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2001 - 2013年加拿大安大略省与非结核分枝杆菌相关的肺部死亡病例

Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.

作者信息

Marras Theodore K, Campitelli Michael A, Lu Hong, Chung Hannah, Brode Sarah K, Marchand-Austin Alex, Winthrop Kevin L, Gershon Andrea S, Kwong Jeffrey C, Jamieson Frances B

出版信息

Emerg Infect Dis. 2017 Mar;23(3):468-476. doi: 10.3201/eid2303.161927.

DOI:10.3201/eid2303.161927
PMID:28221106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5382758/
Abstract

Survival implications of nontuberculous mycobacterial pulmonary disease (NTM-PD) and NTM pulmonary isolation without disease (NTM-PI) are unclear. To study deaths associated with NTM-PD and NTM-PI and differences in survival between them, we conducted a population-based cohort study of persons with microbiologically defined NTM-PD or NTM-PI diagnosed during 2001-2013 in Ontario, Canada. We used propensity score matching and Cox proportional hazards models to compare survival. Among 9,681 NTM-PD patients and 10,936 NTM-PI patients, 87% and 91%, respectively, were successfully matched with unexposed controls. Both NTM-PD and NTM-PI were associated with higher rates of death for all species combined and for most individual species. Compared with NTM-PI, NTM-PD was associated with higher death rates for all species combined, Mycobacterium avium complex, and M. xenopi. NTM-PD and NTM-PI were significantly associated with death, NTM-PD more so than NTM-PI.

摘要

非结核分枝杆菌肺病(NTM-PD)及无疾病的非结核分枝杆菌肺部定植(NTM-PI)对生存的影响尚不清楚。为研究与NTM-PD和NTM-PI相关的死亡情况以及二者之间生存差异,我们对2001年至2013年期间在加拿大安大略省微生物学确诊为NTM-PD或NTM-PI的人群进行了一项基于人群的队列研究。我们使用倾向评分匹配和Cox比例风险模型来比较生存率。在9681例NTM-PD患者和10936例NTM-PI患者中,分别有87%和91%成功与未暴露对照组进行匹配。NTM-PD和NTM-PI在所有菌种合并及大多数单个菌种中均与较高的死亡率相关。与NTM-PI相比,NTM-PD在所有菌种合并、鸟分枝杆菌复合群及偶发分枝杆菌中与更高的死亡率相关。NTM-PD和NTM-PI均与死亡显著相关,NTM-PD比NTM-PI更甚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aeb/5382758/20461a701ec8/16-1927-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aeb/5382758/20461a701ec8/16-1927-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aeb/5382758/20461a701ec8/16-1927-F.jpg

相似文献

1
Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.2001 - 2013年加拿大安大略省与非结核分枝杆菌相关的肺部死亡病例
Emerg Infect Dis. 2017 Mar;23(3):468-476. doi: 10.3201/eid2303.161927.
2
Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012.2001-2012 年加拿大安大略省非结核分枝杆菌感染相关成本。
Emerg Infect Dis. 2020 Sep;26(9):2097-2107. doi: 10.3201/eid2609.190524.
3
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.日本一家转诊医院中,非结核分枝杆菌肺病和结核病的流行病学和临床特征的相互关系变化。
Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.
4
Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020.加拿大安大略省非结核分枝杆菌肺病,2020 年。
Emerg Infect Dis. 2023 Jul;29(7):1415-1419. doi: 10.3201/eid2907.230216.
5
Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.加拿大安大略省肺型与非肺型非结核分枝杆菌。
Emerg Infect Dis. 2017 Nov;23(11):1898-1901. doi: 10.3201/eid2311.170959.
6
Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007.2007 年安大略省肺部非结核分枝杆菌的分离流行率。
Can Respir J. 2011 Jan-Feb;18(1):19-24. doi: 10.1155/2011/865831.
7
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.从肺部样本中分离的非结核分枝杆菌的地理多样性:一项 NTM-NET 合作研究。
Eur Respir J. 2013 Dec;42(6):1604-13. doi: 10.1183/09031936.00149212. Epub 2013 Apr 18.
8
Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010.北卡罗来纳州中部居民中分离出的非结核分枝杆菌的流行病学研究,2006-2010 年。
J Infect. 2016 Jun;72(6):678-686. doi: 10.1016/j.jinf.2016.03.008. Epub 2016 Mar 18.
9
Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.希腊肺部疾病治疗患者中非结核分枝杆菌的分布——与微生物学数据的关系
Future Microbiol. 2015;10(8):1301-6. doi: 10.2217/FMB.15.50. Epub 2015 Jul 30.
10
Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.非结核分枝杆菌肺部感染患者的死亡危险因素:一项回顾性队列研究。
Respir Med. 2015 Jan;109(1):137-45. doi: 10.1016/j.rmed.2014.10.013. Epub 2014 Nov 12.

引用本文的文献

1
NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.基于血清细胞外囊泡蛋白质组分析,NHERF2作为区分MAC肺部疾病与结核病的新型生物标志物
Int J Mol Sci. 2025 Jan 29;26(3):1155. doi: 10.3390/ijms26031155.
2
A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom.英国疑似非结核分枝杆菌肺病(NTM-PD)诊断与管理实用指南
NPJ Prim Care Respir Med. 2024 Dec 21;34(1):45. doi: 10.1038/s41533-024-00403-9.
3
Effect of comorbidities on mortality in patients with nontuberculous mycobacterial infection in Korea: National Health Insurance Service-National Sample Cohort data.

本文引用的文献

1
Mortality among patients with pulmonary non-tuberculous mycobacteria disease.肺非结核分枝杆菌病患者的死亡率。
Int J Tuberc Lung Dis. 2016 May;20(5):582-7. doi: 10.5588/ijtld.15.0807.
2
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.2007年至2012年俄勒冈州非结核分枝杆菌肺病的人群发病率
Ann Am Thorac Soc. 2015 May;12(5):642-7. doi: 10.1513/AnnalsATS.201412-559OC.
3
Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.人类非结核分枝杆菌肺部感染的流行病学:综述
韩国非结核分枝杆菌感染患者合并症对死亡率的影响:国家健康保险服务-国家样本队列数据。
Sci Rep. 2024 Oct 1;14(1):22815. doi: 10.1038/s41598-024-73768-z.
4
CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis.基于CT的影像组学分析在鉴别非结核分枝杆菌肺病与肺结核的实变特征中的应用
Exp Ther Med. 2024 Jan 24;27(3):112. doi: 10.3892/etm.2024.12400. eCollection 2024 Mar.
5
Pulmonary infection treated in combination with inhaled tigecycline.联合使用替加环素治疗肺部感染。
BMJ Case Rep. 2023 Dec 16;16(12):e255383. doi: 10.1136/bcr-2023-255383.
6
Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease.美国医疗保险受益人群中慢性阻塞性肺疾病合并非结核分枝杆菌肺病的增量死亡率。
BMC Infect Dis. 2023 Nov 1;23(1):749. doi: 10.1186/s12879-023-08689-9.
7
The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease.非结核分枝杆菌菌种对非结核分枝杆菌肺病患者死亡率的影响
Front Microbiol. 2022 Jul 7;13:909274. doi: 10.3389/fmicb.2022.909274. eCollection 2022.
8
Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study.台湾地区需要治疗的非结核分枝杆菌感染的死亡率相关性:一项基于人群的研究。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221103213. doi: 10.1177/17534666221103213.
9
Novel case of empyema necessitans caused by .由. 引起的复杂性脓胸一例。
BMJ Case Rep. 2022 May 12;15(5):e245953. doi: 10.1136/bcr-2021-245953.
10
Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.抗酸分枝杆菌糖脂抗体作为鸟分枝杆菌胞内复合体肺病的生物标志物与长期预后的关系。
Microbiol Spectr. 2022 Jun 29;10(3):e0053022. doi: 10.1128/spectrum.00530-22. Epub 2022 Apr 25.
Clin Chest Med. 2015 Mar;36(1):13-34. doi: 10.1016/j.ccm.2014.10.002. Epub 2014 Nov 6.
4
Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada.加拿大安大略省类风湿关节炎相关分枝杆菌感染风险。
Chest. 2014 Sep;146(3):563-572. doi: 10.1378/chest.13-2058.
5
Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi.比较鸟分枝杆菌复合群和胞内分枝杆菌引起的肺部疾病的放射学和临床表现的光谱。
Can Assoc Radiol J. 2014 Aug;65(3):207-13. doi: 10.1016/j.carj.2013.05.006. Epub 2013 Dec 8.
6
Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010.加拿大安大略省 1998-2010 年非结核分枝杆菌肺病。
Emerg Infect Dis. 2013 Nov;19(11):1889-91. doi: 10.3201/eid1911.130737.
7
Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011.1993-2011 年巴西肺部非结核分枝杆菌病的临床和治疗特征。
Emerg Infect Dis. 2013 Mar;19(3):393-9. doi: 10.3201/eid/1903.120735.
8
Prognostic value of American Thoracic Society criteria for non-tuberculous mycobacterial disease: a retrospective analysis of 120 cases with four years of follow-up.美国胸科学会标准对非结核分枝杆菌病的预后价值:120例患者4年随访的回顾性分析
Scand J Infect Dis. 2013 Mar;45(3):194-202. doi: 10.3109/00365548.2012.722227. Epub 2012 Oct 7.
9
Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.美国医疗保险受益人群中非结核分枝杆菌肺病的流行率。
Am J Respir Crit Care Med. 2012 Apr 15;185(8):881-6. doi: 10.1164/rccm.201111-2016OC. Epub 2012 Feb 3.
10
Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease.肺鸟分枝杆菌复合群病 5 年死亡率的预测因素。
Int J Tuberc Lung Dis. 2012;16(3):408-14. doi: 10.5588/ijtld.11.0148. Epub 2012 Jan 5.